Stayble Therapeutics

[{"orgOrder":0,"company":"Stayble Therapeutics","sponsor":"Cromsource | Antaros Medical | Viedoc","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"SWEDEN","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Lactic Acid","moa":"Bifunctional protein PutA; NimA-related protein","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Phase I","graph3":"Stayble Therapeutics","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Stayble Therapeutics \/ Cromsource | Antaros Medical | Viedoc","highestDevelopmentStatusID":"6","companyTruncated":"Stayble Therapeutics \/ Cromsource | Antaros Medical | Viedoc"},{"orgOrder":0,"company":"Stayble Therapeutics","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SWEDEN","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"STA363","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase II","graph3":"Stayble Therapeutics","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Injection","sponsorNew":"Stayble Therapeutics \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Stayble Therapeutics \/ Undisclosed"},{"orgOrder":0,"company":"Stayble Therapeutics","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SWEDEN","productType":"Undisclosed","year":"2017","type":"Inapplicable","leadProduct":"STA363","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase I","graph3":"Stayble Therapeutics","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Stayble Therapeutics \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Stayble Therapeutics \/ Undisclosed"}]